Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
45,476,673
-
Share change
-
+8,404,772
-
Total reported value
-
$1,205,199,236
-
Put/Call ratio
-
141%
-
Price per share
-
$26.50
-
Number of holders
-
102
-
Value change
-
+$228,807,941
-
Number of buys
-
56
-
Number of sells
-
46
Institutional Holders of RUBIUS THERAPEUTICS INC - COM (RUBY) as of Q1 2021
As of 31 Mar 2021,
RUBIUS THERAPEUTICS INC - COM (RUBY) was held by
102 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
45,476,673 shares.
The largest 10 holders included
FMR LLC, Artal Group S.A., BAILLIE GIFFORD & CO, BlackRock Inc., VANGUARD GROUP INC, JPMORGAN CHASE & CO, Capital World Investors, Abbot Financial Management, Inc., FEDERATED HERMES, INC., and VICTORY CAPITAL MANAGEMENT INC.
This page lists
102
institutional shareholders reporting positions in this security
for the Q1 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.